Tokyo Tape
Sign in
← Kubota Pharmaceutical Holdings

Quarterly report · Q3

4596.TEDINET S100SAAA
Period2023-01-01 → 2023-09-30
Filed2023-11-14
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 60
MetricValuePeriodScopeSource row
Revenue¥31m2023-01-01 → 2023-09-30Cons.Revenue IFRS (5-year summary)
Revenue¥13m2023-07-01 → 2023-09-30dCons.Revenue IFRS (5-year summary)
Revenue¥8m2022-01-01 → 2022-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥3m2022-01-01 → 2022-09-30Cons.Revenue IFRS (5-year summary)
Operating income−¥1.0bn2023-01-01 → 2023-09-30Cons.Operating profit loss IFRS
Operating income−¥283m2023-07-01 → 2023-09-30dCons.Operating profit loss IFRS
Operating income−¥1.7bn2022-01-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income−¥481m2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Profit before tax−¥1.0bn2023-01-01 → 2023-09-30Cons.Profit loss before tax IFRS
Profit before tax−¥282m2023-07-01 → 2023-09-30dCons.Profit loss before tax IFRS
Profit before tax−¥2.0bn2022-01-01 → 2022-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax−¥1.7bn2022-01-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax−¥484m2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Net income (owners)−¥1.0bn2023-01-01 → 2023-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥282m2023-07-01 → 2023-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥2.0bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)−¥1.7bn2022-01-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥484m2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income−¥1.0bn2023-01-01 → 2023-09-30Cons.Profit loss IFRS
Net income−¥282m2023-07-01 → 2023-09-30dCons.Profit loss IFRS
Net income−¥1.7bn2022-01-01 → 2022-09-30Cons.Profit loss IFRS
Net income−¥484m2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Total assets¥3.5bnat 2023-09-30Cons.Assets IFRS
Total assets¥4.4bnat 2022-12-31Cons.Assets IFRS
Total assets¥4.7bnat 2022-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥372mat 2023-09-30Cons.Liabilities IFRS
Total liabilities¥470mat 2022-12-31Cons.Liabilities IFRS
Net assets / equity¥3.1bnat 2023-09-30Cons.Equity IFRS
Net assets / equity¥3.9bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥4.1bnat 2022-09-30Cons.Equity IFRS
Net assets / equity¥4.2bnat 2021-12-31dCons.Equity IFRS
Equity (owners)¥3.1bnat 2023-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥3.9bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥4.1bnat 2022-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥3.1bnat 2023-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥4.0bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥4.4bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥4.0bnat 2021-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow−¥1.0bn2023-01-01 → 2023-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow−¥2.1bn2022-01-01 → 2022-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow−¥1.7bn2022-01-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥21m2023-01-01 → 2023-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow¥505m2022-01-01 → 2022-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow¥566m2022-01-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥111m2023-01-01 → 2023-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥1.4bn2022-01-01 → 2022-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥1.2bn2022-01-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-18.532023-01-01 → 2023-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-5.062023-07-01 → 2023-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥-40.922022-01-01 → 2022-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥-35.22022-01-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-9.452022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥-18.532023-01-01 → 2023-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-5.062023-07-01 → 2023-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥-40.922022-01-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥-35.22022-01-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-9.452022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio89.4%at 2023-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio89.4%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio86.8%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 437
ItemContextValueUnit
Comprehensive income IFRSCurrentYTDDuration_ShareCapitalIFRSMember－JPY
Comprehensive income IFRSCurrentYTDDuration_CapitalSurplusIFRSMember－JPY
Comprehensive income IFRSCurrentYTDDuration_RetainedEarningsIFRSMember-1027086000JPY
Comprehensive income IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember34877000JPY
Comprehensive income IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-992209000JPY
Comprehensive income IFRSCurrentYTDDuration-992209000JPY
Share based payment transactions ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember33613000JPY
Share based payment transactions ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember33613000JPY
Share based payment transactions ss IFRSCurrentYTDDuration33613000JPY
Issuance of new shares ss IFRSCurrentYTDDuration_ShareCapitalIFRSMember74407000JPY
Issuance of new shares ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember74407000JPY
Issuance of new shares ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember148814000JPY
Issuance of new shares ss IFRSCurrentYTDDuration148814000JPY
Cost of issuance of new shares ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember-1162000JPY
Cost of issuance of new shares ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-1162000JPY
Cost of issuance of new shares ss IFRSCurrentYTDDuration-1162000JPY
Total transactions with owners IFRSCurrentYTDDuration_ShareCapitalIFRSMember74407000JPY
Total transactions with owners IFRSCurrentYTDDuration_CapitalSurplusIFRSMember106858000JPY
Total transactions with owners IFRSCurrentYTDDuration_RetainedEarningsIFRSMember－JPY
Total transactions with owners IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Total transactions with owners IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember181265000JPY
Total transactions with owners IFRSCurrentYTDDuration181265000JPY
Equity IFRSCurrentQuarterInstant_ShareCapitalIFRSMember2141113000JPY
Equity IFRSCurrentQuarterInstant_CapitalSurplusIFRSMember27633711000JPY
Equity IFRSCurrentQuarterInstant_RetainedEarningsIFRSMember-25207740000JPY
Equity IFRSCurrentQuarterInstant_OtherComponentsOfEquityIFRSMember-1428493000JPY
Equity IFRSCurrentQuarterInstant_EquityAttributableToOwnersOfParentIFRSMember3138591000JPY
Equity IFRSCurrentQuarterInstant3138591000JPY
Profit loss IFRSPrior1YTDDuration-1680869000JPY
Profit loss IFRSCurrentYTDDuration-1027086000JPY
Depreciation expense ope cf IFRSPrior1YTDDuration42330000JPY
Depreciation expense ope cf IFRSCurrentYTDDuration63668000JPY
Stock based compensation ope cf IFRSPrior1YTDDuration12837000JPY
Stock based compensation ope cf IFRSCurrentYTDDuration33613000JPY
Amortization net of premium discount on marketable securities ope cf IFRSPrior1YTDDuration-1461000JPY
Amortization net of premium discount on marketable securities ope cf IFRSCurrentYTDDuration－JPY
Loss gain on sale and retirement of fixed assets ope cf IFRSPrior1YTDDuration-2247000JPY
Loss gain on sale and retirement of fixed assets ope cf IFRSCurrentYTDDuration2026000JPY
Finance income ope cf IFRSPrior1YTDDuration-10544000JPY
Finance income ope cf IFRSCurrentYTDDuration-10296000JPY
Finance costs ope cf IFRSPrior1YTDDuration9010000JPY
Finance costs ope cf IFRSCurrentYTDDuration7197000JPY
Trade receivables ope cf IFRSPrior1YTDDuration-3713000JPY
Trade receivables ope cf IFRSCurrentYTDDuration-431000JPY
Other current assets ope cf IFRSPrior1YTDDuration100847000JPY
Other current assets ope cf IFRSCurrentYTDDuration18971000JPY
Other current liabilities ope cf IFRSPrior1YTDDuration－JPY
Other current liabilities ope cf IFRSCurrentYTDDuration-160000JPY
Accounts payable ope cf IFRSPrior1YTDDuration-16229000JPY
Accounts payable ope cf IFRSCurrentYTDDuration6611000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass